Collegium Pharmaceutical Inc (COLL)
Operating return on assets (Operating ROA)
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating income (ttm) | US$ in thousands | 169,895 | 193,472 | 203,646 | 191,808 | 166,961 | 74,953 | 50,407 | 25,884 | -8,754 | -12,556 | -18,874 | -13,575 | 17,628 | 66,746 | 72,223 | 72,363 | 56,232 | 38,863 | 12,862 | -8,695 |
| Total assets | US$ in thousands | 1,663,590 | 1,635,150 | 1,053,390 | 1,114,250 | 1,143,310 | 1,177,580 | 1,213,910 | 1,214,300 | 1,174,130 | 1,200,940 | 1,245,570 | 1,246,140 | 692,077 | 741,803 | 713,735 | 646,065 | 643,841 | 643,843 | 646,870 | 634,793 |
| Operating ROA | 10.21% | 11.83% | 19.33% | 17.21% | 14.60% | 6.37% | 4.15% | 2.13% | -0.75% | -1.05% | -1.52% | -1.09% | 2.55% | 9.00% | 10.12% | 11.20% | 8.73% | 6.04% | 1.99% | -1.37% |
December 31, 2024 calculation
Operating ROA = Operating income (ttm) ÷ Total assets
= $169,895K ÷ $1,663,590K
= 10.21%
Operating return on assets (Operating ROA) is a financial ratio that provides insight into how efficiently a company is generating profits from its assets solely related to its core operations. The trend analysis of Collegium Pharmaceutical Inc's Operating ROA from March 31, 2020, to December 31, 2024, reveals fluctuations in the company's operational efficiency over time.
Collegium Pharmaceutical Inc's Operating ROA started with a negative value of -1.37% on March 31, 2020, indicating that the company was not effectively utilizing its assets to generate operating profits. However, over the next few quarters, the Operating ROA improved significantly, reaching its peak at 19.33% on June 30, 2024. This surge in operational efficiency suggests that Collegium Pharmaceutical Inc was able to enhance its profitability relative to its asset base during this period.
Subsequently, the Operating ROA experienced a slight decline in the following periods, stabilizing around the range of 10% to 15%. While the ratios remained relatively healthy, the declining trend from June 30, 2024, to December 31, 2024, hints at potential challenges in sustaining the high level of operational profitability seen earlier.
Overall, the fluctuating pattern in Collegium Pharmaceutical Inc's Operating ROA underscores the variability in the company's ability to generate operating profits from its assets. It is essential for investors and stakeholders to monitor this ratio closely to assess the company's operational efficiency and its ability to create value from its asset base.
Peer comparison
Dec 31, 2024